Article Details

Imugene to be granted European patent for cancer vaccine | ASX:IMU, OTC:IUGNF

Retrieved on: 2023-12-05 22:21:19

Tags for this article:

Click the tags to see associated articles and topics

Imugene to be granted European patent for cancer vaccine | ASX:IMU, OTC:IUGNF. View article details on HISWAI: https://www.proactiveinvestors.co.uk/companies/news/1035291/imugene-to-be-granted-european-patent-for-cancer-vaccine-1035291.html

Excerpt

... monoclonal antibodies. These antibodies are significantly changing the landscape of treatment for various types of cancers. View Price & Profile.

Article found on: www.proactiveinvestors.co.uk

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up